BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 34968245)

  • 1. Clinical Utility of Epigenetic Changes in Pancreatic Adenocarcinoma.
    Thompson JK; Bednar F
    Epigenomes; 2021 Sep; 5(4):. PubMed ID: 34968245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of epigenetics in pancreatic ductal adenocarcinoma.
    Pandey S; Gupta VK; Lavania SP
    Epigenomics; 2023 Jan; 15(2):89-110. PubMed ID: 36647796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetics in Pancreatic Ductal Adenocarcinoma: Impact on Biology and Utilization in Diagnostics and Treatment.
    Elrakaybi A; Ruess DA; Lübbert M; Quante M; Becker H
    Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current clinical trials for epigenetic targets and therapeutic inhibitors for pancreatic cancer therapy.
    Ganji C; Farran B
    Drug Discov Today; 2022 May; 27(5):1404-1410. PubMed ID: 34952224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic reprogramming in pancreatic premalignancy and clinical implications.
    Zhang W; Jiang T; Xie K
    Front Oncol; 2023; 13():1024151. PubMed ID: 36874143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic Therapeutic Strategies to Target Molecular and Cellular Heterogeneity in Pancreatic Cancer.
    Versemann L; Hessmann E; Ulisse M
    Visc Med; 2022 Feb; 38(1):11-19. PubMed ID: 35291698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetics and pancreatic cancer: pathophysiology and novel treatment aspects.
    Neureiter D; Jäger T; Ocker M; Kiesslich T
    World J Gastroenterol; 2014 Jun; 20(24):7830-48. PubMed ID: 24976721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy.
    Kawakubo K; Castillo CF; Liss AS
    J Gastroenterol; 2022 Nov; 57(11):819-826. PubMed ID: 36048239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-Free DNA Methylation as Blood-Based Biomarkers for Pancreatic Adenocarcinoma-A Literature Update.
    Henriksen SD; Thorlacius-Ussing O
    Epigenomes; 2021 Apr; 5(2):. PubMed ID: 34968295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic Biomarkers in the Management of Ovarian Cancer: Current Prospectives.
    Singh A; Gupta S; Sachan M
    Front Cell Dev Biol; 2019; 7():182. PubMed ID: 31608277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetics of thyroid cancer and novel therapeutic targets.
    Russo D; Damante G; Puxeddu E; Durante C; Filetti S
    J Mol Endocrinol; 2011 Jun; 46(3):R73-81. PubMed ID: 21325372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting cancer epigenetics: Linking basic biology to clinical medicine.
    Shinjo K; Kondo Y
    Adv Drug Deliv Rev; 2015 Dec; 95():56-64. PubMed ID: 26494398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic alterations as biomarkers in pancreatic ductal adenocarcinoma.
    Syren P; Andersson R; Bauden M; Ansari D
    Scand J Gastroenterol; 2017; 52(6-7):668-673. PubMed ID: 28301276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Epigenetic Markers for Precision Medicine.
    Dumitrescu RG
    Methods Mol Biol; 2018; 1856():3-17. PubMed ID: 30178243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Non-Coding RNAs and Metabolic Rewiring in Pancreatic Cancer.
    Dalmasso B; Ghiorzo P
    Cancers (Basel); 2023 Jul; 15(13):. PubMed ID: 37444595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium Signaling Alterations Caused by Epigenetic Mechanisms in Pancreatic Cancer: From Early Markers to Prognostic Impact.
    Gregório C; Soares-Lima SC; Alemar B; Recamonde-Mendoza M; Camuzi D; de Souza-Santos PT; Rivero R; Machado S; Osvaldt A; Ashton-Prolla P; Pinto LFR
    Cancers (Basel); 2020 Jun; 12(7):. PubMed ID: 32629766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Overview of Epigenetic Methylation in Pancreatic Cancer Progression.
    Zhao Y; Yang M; Wang S; Abbas SJ; Zhang J; Li Y; Shao R; Liu Y
    Front Oncol; 2022; 12():854773. PubMed ID: 35296007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential methylation landscape of pancreatic ductal adenocarcinoma and its precancerous lesions.
    Bararia A; Dey S; Gulati S; Ghatak S; Ghosh S; Banerjee S; Sikdar N
    Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):205-217. PubMed ID: 32312637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic Alterations in Pancreatic Cancer Metastasis.
    Wang SS; Xu J; Ji KY; Hwang CI
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Aspects of the Epigenetics of Pancreatic Carcinogenesis.
    Toruner M; Fernandez-Zapico ME; Pin CL
    Epigenomes; 2020 Sep; 4(3):. PubMed ID: 33014438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.